Global pharmaceutical firms are expecting to reduce the amount of real estate they own in a trend that could create a new market for property investors.
You must be logged in to view premium stories.
Take out a print and online or online only subscription and you will get immediate access to:
To get access to premium content subscribe today
Alternatively REGISTER for a free trial to access up to 4 articles and sign up for email alerts